| Comprehensive assessment of T-cell receptor β-chain diversity in αβ T cells HS Robins, PV Campregher, SK Srivastava, A Wacher, CJ Turtle, ... Blood, The Journal of the American Society of Hematology 114 (19), 4099-4107, 2009 | 1233 | 2009 |
| Overlap and effective size of the human CD8+ T cell receptor repertoire HS Robins, SK Srivastava, PV Campregher, CJ Turtle, J Andriesen, ... Science translational medicine 2 (47), 47ra64-47ra64, 2010 | 477 | 2010 |
| Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD AC Vigorito, PV Campregher, BE Storer, PA Carpenter, CK Moravec, ... Blood, The Journal of the American Society of Hematology 114 (3), 702-708, 2009 | 277 | 2009 |
| HER2 transmembrane domain (TMD) mutations (V659/G660) that stabilize homo-and heterodimerization are rare oncogenic drivers in lung adenocarcinoma that respond to afatinib SHI Ou, AB Schrock, EV Bocharov, SJ Klempner, CK Haddad, ... Journal of Thoracic Oncology 12 (3), 446-457, 2017 | 88 | 2017 |
| Prognostic impact of RAS-pathway mutations in patients with myelofibrosis FPS Santos, B Getta, L Masarova, C Famulare, J Schulman, TS Datoguia, ... Leukemia 34 (3), 799-810, 2020 | 57 | 2020 |
| Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease MED Flowers, B Storer, P Carpenter, AR Rezvani, AC Vigorito, ... Biology of Blood and Marrow Transplantation 14 (12), 1380-1384, 2008 | 55 | 2008 |
| Results of donor lymphocyte infusions for relapsed myelodysplastic syndrome after hematopoietic cell transplantation PV Campregher, T Gooley, BL Scott, C Moravec, B Sandmaier, PJ Martin, ... Bone marrow transplantation 40 (10), 965-971, 2007 | 51 | 2007 |
| Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics … P Horak, M Griffith, AM Danos, BA Pitel, S Madhavan, X Liu, C Chow, ... Genetics in Medicine 24 (5), 986-998, 2022 | 45 | 2022 |
| Lung function and long-term complications after allogeneic hematopoietic cell transplant EC Walter, M Orozco-Levi, A Ramirez-Sarmiento, A Vigorito, ... Biology of Blood and Marrow Transplantation 16 (1), 53-61, 2010 | 41 | 2010 |
| Molecular biology of Philadelphia-negative myeloproliferative neoplasms PV Campregher, FPS Santos, GF Perini, N Hamerschlak Revista Brasileira de Hematologia e Hemoterapia 34, 150-155, 2012 | 32 | 2012 |
| Granulocyte whole exome sequencing and endothelial JAK2V617F in patients with JAK2V617F positive Budd-Chiari Syndrome without myeloproliferative neoplasm R Helman, W de O Pereira, LC Marti, PV Campregher, RD Puga, ... British journal of haematology 180 (3), 443-445, 2018 | 29 | 2018 |
| Multi-center real-world comparison of the fully automated Idylla™ microsatellite instability assay with routine molecular methods and immunohistochemistry on formalin-fixed … A Velasco, F Tokat, J Bonde, N Trim, E Bauer, A Meeney, W de Leng, ... Virchows Archiv 478, 851-863, 2021 | 26 | 2021 |
| High body mass index among patients undergoing hematopoietic stem cell transplantation: results of a cross-sectional evaluation of nutritional status in a private hospital AZ Pereira, ES Victor, PV Campregher, SMF Piovacari, JSB Barban, ... Nutricion hospitalaria 32 (6), 2874-2879, 2015 | 22 | 2015 |
| Abnormalities of the αβ T-cell receptor repertoire in advanced myelodysplastic syndrome PV Campregher, SK Srivastava, HJ Deeg, HS Robins, EH Warren Experimental hematology 38 (3), 202-212, 2010 | 22 | 2010 |
| Novel prognostic gene mutations identified in chronic lymphocytic leukemia and their impact on clinical practice PV Campregher, N Hamerschlak Clinical Lymphoma Myeloma and Leukemia 14 (4), 271-276, 2014 | 17 | 2014 |
| Survival and graft‐versus‐host disease in patients receiving peripheral stem cell compared to bone marrow transplantation from HLA‐matched related donor: retrospective analysis … PV Campregher, N Hamerschlak, VAR Colturato, MA Mauad, ... European Journal of Haematology 95 (5), 421-425, 2015 | 16 | 2015 |
| Identification of a novel fusion TBL1XR1–PDGFRB in a patient with acute myeloid leukemia harboring the DEK–NUP214 fusion and clinical response to dasatinib PV Campregher, NS Halley, GA Vieira, JF Fernandes, EDRP Velloso, ... Leukemia & Lymphoma 58 (12), 2969-2972, 2017 | 15 | 2017 |
| The role of magnetic resonance imaging‐T 2* in the evaluation of iron overload early in hereditary hemochromatosis. A cross‐sectional study with 159 patients RA Assis, FU Kay, FM Conti, PV Campregher, G Szarf, MS Diniz, ... American journal of hematology 90 (12), E220-E221, 2015 | 15 | 2015 |
| Autophagy inhibition potentiates ruxolitinib-induced apoptosis in JAK2V617F cells JA Machado-Neto, JL Coelho-Silva, FPS Santos, PS Scheucher, ... Investigational New Drugs 38, 733-745, 2020 | 14 | 2020 |
| A novel mechanism of NPM1 cytoplasmic localization in acute myeloid leukemia: the recurrent gene fusion NPM1–HAUS1 PV Campregher, W de Oliveira Pereira, B Lisboa, R Puga, ... Haematologica 101 (7), e287, 2016 | 14 | 2016 |
Nelson Hamerschlakmaria Flora e Israel HamerschlakVerified email at einstein.br
